Changes of pneumonia patients bronchoalveolar lavage fluid cellular components Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Involvement of lymphocytes in mycoplasma pneumoniae pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007
Levels of interferon-γ and interleukin-2 receptor-α for bronchoalveolar lavage fluid were correlated with clinical grade and treatment course of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 530s Year: 2001
Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis Source: Annual Congress 2012 - Sarcoidosis Year: 2012
Cytokine profiles in bronchoalveolar lavage fluid in patients with pneumocystis pneumonia Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
Quantitative cultures of bronchoalveolar lavage fluid during the course of pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012